MRSA affects over 100,000 people every year within the NHS causing an estimated 5,000 deaths in the UK. The MRSA bacteria is so common that it is carried on the skin of one in three people in the UK. (known as comunity aquired MRSA). Hand washing alone cannot stop the spread of this bacteria in the hospital environment. The only way to rid these clinical environments of infection is to use a cleaning disinfectant that annihilates the bacteria completely, preventing further mutation and rendering the environment hostile to any further infection.

The Hospital Infection Research Laborartory, Retroscreen Virology, Lawlabs and Texcell Labs (Paris) have all given VIRUSOLVE+ their approval in fighting hospital 'superbugs' including MRSA and Clostridium Difficile spores.

Independently Proven PerformanceManufactured within the U.K, Virusolve+ has also undergone rigorous testing at Europe’s leading laboratories, including: The Hospital Infection Research Laboratory in Birmingham, The Texcell Laboratory (Part of Institute Pasteur®), Paris, and the UK Health Protection Agency.
Virusolve+ is CE Marked (CE0120). Hence all of the claims have been audited and verified on behalf of the UK regulator MHRA (Medicines and Healthcare products Regulatory Agency).